A phase II/III, randomized, double-blind, placebo-controlled trial to evaluate immunogenicity and safety of the Gam-COVID-Vac combined vector vaccine in the prophylactic treatment... by Ahmed A.K. AlHammadi, Amna H. Alzaabi, Haneen B. Choker, Ahmed A. Ibrahim, Asma Bin Ishaq, Ahmed E. Mahboub, Reem S. Al Dhaheri, Mohamed N. Alzaabi, Timothy A. Collyns, Gehad ElGhazali, Stefan Weber, Basel K. Al-Ramadi

Get full text